Polaris Venture Management Co. V, L.L.C. - Q2 2018 holdings

$183 Million is the total value of Polaris Venture Management Co. V, L.L.C.'s 12 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 9.1% .

 Value Shares↓ Weighting
CDLX  Cardlytics, Inc.$57,365,000
+48.7%
2,636,2620.0%31.26%
+42.2%
FATE  Fate Therapeutics, Inc.$28,046,000
+16.2%
2,473,1860.0%15.28%
+11.1%
KALA  Kala Pharmaceuticals, Inc.$25,505,000
-13.3%
1,857,5820.0%13.90%
-17.1%
STIM NewNeuronetics, Inc.$21,947,000824,765
+100.0%
11.96%
SELB  Selecta Biosciences, Inc.$21,290,000
+30.0%
1,606,8130.0%11.60%
+24.3%
TTOO SellT2 Biosystems, Inc.$14,257,000
+17.1%
1,841,924
-1.8%
7.77%
+12.0%
ASNS  Arsanis, Inc.$6,784,000
-84.1%
1,868,9570.0%3.70%
-84.8%
TRVN  Trevena, Inc.$2,957,000
-12.2%
2,053,5400.0%1.61%
-16.1%
GNCA  Genocea Biosciences, Inc.$1,685,000
-18.5%
1,968,6060.0%0.92%
-22.1%
LIFE  Atyr Pharma Inc.$1,663,000
-65.7%
1,827,9920.0%0.91%
-67.2%
PULM BuyPulmatrix, Inc.$1,617,000
+13.6%
3,594,381
+28.5%
0.88%
+8.6%
DARE  Dare Bioscience, Inc.$382,000
+39.9%
326,2430.0%0.21%
+33.3%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-08-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
Fate Therapeutics, Inc.30Q2 202179.2%
Atyr Pharma Inc.26Q3 202115.1%
Trevena, Inc.22Q2 201924.9%
Genocea Biosciences, Inc.21Q1 201932.5%
Selecta Biosciences, Inc.20Q1 202139.5%
T2 Biosystems, Inc.20Q2 201936.1%
Dare Bioscience, Inc.17Q3 20213.9%
Pulmatrix, Inc.16Q1 201915.4%
Cerulean Pharma Inc13Q2 201716.2%
Kala Pharmaceuticals, Inc.11Q1 202037.1%

View Polaris Venture Management Co. V, L.L.C.'s complete holdings history.

Latest filings
TypeFiled
32022-03-30
13F-HR2021-11-12
13F-HR2021-08-12
13F-HR2021-05-12
13F-HR2021-02-12
13F-HR2020-11-12
13F-HR2020-08-12
13F-HR2020-05-14
42020-05-06
32020-04-30

View Polaris Venture Management Co. V, L.L.C.'s complete filings history.

Compare quarters

Export Polaris Venture Management Co. V, L.L.C.'s holdings